
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Clovis Unified students spend spring break traveling through China - 2
Shelby County deputies charged with assault, placed on leave - 3
Doctors looking into hormone therapy as a way to ward off dementia in women - 4
How on earth did 'Shark Tank' star Kevin O'Leary end up in 'Marty Supreme'? I'll let him explain. - 5
‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
Can scientists detect life without knowing what it looks like? Research using machine learning offers a new way
Noctourism: the new safari travel trend that's changing the wildlife we can photograph in Africa
Netflix’s Price Hikes Just Got Rejected by an Italian Court. Here’s Why It Matters Everywhere
Hezbollah field commander killed in IDF strikes in Beirut
Share your pick for the tree that you love for its novel magnificence!
FDA approves Wegovy pill for weight loss: What to know
Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
The beauty advent calendar boom is here. Sephora kids are all in.
How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker













